改善心血管疾病患者用药依从性的系统综述
该系统综述评估并比较了改善动脉粥样硬化性心血管疾病(ASCVD)二级预防用药依从性的干预措施效果。三种干预(短信服务、固定剂量复方制剂、基于社区卫生工作者的干预)同时改善了依从性和临床结局。
要点
- 短信服务干预组高依从性比例65% vs 对照组13%。
- 固定剂量复方制剂依从率86% vs 65%,依从风险比1.33(95%CI 1.26-1.41)。
- 社区卫生工作者干预依从率97% vs 92%,OR=2.62(95%CI 1.32-5.19)。
核心结论
- 三种干预(短信服务、固定剂量复方制剂、社区卫生工作者干预)同时改善了ASCVD二级预防用药依从性和临床结局。
- 需要更长期的试验来确定短期依从性改善能否维持并影响临床事件。
研究设计与样本
- 纳入标准为随机对照试验,研究对象为ASCVD患者,干预旨在改善二级预防用药依从性,并同时测量依从性和临床结局。
主要发现
- 多数试验至少一个领域存在高偏倚风险。
- 干预组依从率范围为44%至99%,对照组依从率范围为13%至96%。
- 短信服务干预组高依从性比例为65%,对照组为13%。
- 固定剂量复方制剂依从率为86% vs 65%,依从风险比1.33(95%CI 1.26至1.41)。
- 社区卫生工作者干预依从率为97% vs 92%,OR=2.62(95%CI 1.32至5.19)。
关键数值与推荐
- 固定剂量复方制剂:依从率86% vs 65%,依从风险比1.33(95%CI 1.26至1.41)。
- 社区卫生工作者干预:依从率97% vs 92%,OR=2.62(95%CI 1.32至5.19)。
- 短信服务干预:高依从性比例65% vs 13%。
临床怎么用
- 可考虑采用短信提醒、固定剂量复方制剂或社区卫生工作者主导的干预来改善ASCVD二级预防用药依从性。
- 选用干预时需结合当地资源与患者特点,并注意多数试验存在高偏倚风险。
局限性
- 多数试验至少一个领域存在高偏倚风险。
- 干预组和对照组依从率范围宽泛(干预组44%-99%,对照组13%-96%),异质性较大。
- 随访时间较短,长期依从性维持及对临床事件的影响尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate and compare the effect of interventions for improving adherence to medications for atherosclerotic cardiovascular disease (ASCVD) secondary prevention. METHODS: We extracted eligible trials from a 2014 Cochrane systematic review on adherence for any condition. We updated the search from CENTRAL, Medline, Embase, PsycINFO, CINAHL, Sociological Abstracts and trial registers through November 2016. Study reports needed to be from a randomised controlled trial, incorporate participants identified as having ASCVD and interventions aimed at improving adherence to medicines for secondary prevention of ASCVD and measure both adherence and a clinical outcome. Two reviewers independently determined the eligibility of studies, extracted data and conducted a narrative synthesis. RESULTS: We identified 17 trials (n=17 448 participants). Most trials had high risk of bias in at least one domain. The intervention group adherence rates ranged from 44%to99% and the comparator group adherence rates ranged from 13% to 96%. Three distinct interventions reported improvements in both adherence and clinical outcomes: short message service (65% vs 13% of participants with high adherence in the intervention vs control group), a fixed-dose combination pill (86% vs 65% adherence, risk ratio of being adherent, 1.33; 95% CI 1.26 to 1.41) and a community health worker-based intervention (97% in the intervention group compared with 92% in the control group; OR=2.62, 95% CI 1.32 to 5.19). CONCLUSIONS: We identified three interventions that demonstrated improvements in adherence and clinical outcomes. Ongoing, longer-term trials will help determine whether short-term changes in adherence can be maintained and lead to differences in clinical events.
引用
- Fuller RH, Perel P, Navarro-Ruan T, et al. Improving medication adherence in patients with cardiovascular disease: a systematic review. Heart. 2018. PMID: 29572248. doi:10.1136/heartjnl-2017-312571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。